Clinical and pathologic characteristics of penile cancer: current experience at a tertiary care hospital center in Mexico
DOI:
https://doi.org/10.48193/revistamexicanadeurologa.v80i5.679Keywords:
penile cancer, pathology, clinical stageAbstract
Background: Squamous cell carcinoma of the penis is considered a rare disease in developed countries, accounting for 0.4-0.6% of the malignant tumors in men, but the figure increases to 10-20% in developing countries. Ninety-five percent of penile cancers correspond to squamous cell carcinoma and the outstanding risk factors are phimosis, smoking, and human papillomavirus infection.
Objective: To describe the clinical and pathologic characteristics of patients diagnosed with penile cancer.
Materials and methods: A retrospective, retrolective, and descriptive study was carried out utilizing the physical and electronic case records of patients treated at the Urology and Oncology Service of the Hospital General de México over the 5-year period of January 2015 to January 2020.
Results: Data on 93 patients were included. Mean age of the patients was 57.87 years (23-86), 55.9% were smokers, and 50% had comorbidities. A total of 65.6% of the patients had a primary school education, 20.4% had a secondary school education, and 7.5% were illiterate. Phimosis was identified in 74.2% and the most frequent penile cancer sites were the glans penis (40.9%), the glans penis-prepuce (33.5%), or the penile body (23.7%). Koilocytosis was present in 17.2%, lymphovascular invasion in 18.3%, and perineural invasion in 19.4%.
Conclusions: Cases of penile cancer are frequent at our hospital and the disease is one of the 20 principal diagnoses made annually. The majority of cases are ulcerous, moderately differentiated, stage T3, clinical stage N0, squamous cell carcinoma.
References
Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano A, Goodman MT, King JB, et al. Burden of Invasive Squamous Cell Carcinoma of the Penis in the United States, 1998–2003. Cancer. 2008 Nov 15;113(10 Suppl):2883–91. doi: https://dx.doi.org/10.1002%2Fcncr.23743
Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. International Journal of Cancer. 2005 Sep 10;116(4):606–16. doi: https://doi.org/10.1002/ijc.21009
Tseng H-F, Morgenstern H, Mack TM, Peters RK. Risk factors for anal cancer: results of a population-based case--control study. Cancer causes & control: CCC. 2003 Nov;14(9):837–46. doi: https://doi.org/10.1023/b:caco.0000003837.10664.7f
Pow-Sang MR, Ferreira U, Pow-Sang JM, Nardi AC, Destefano V. Epidemiology and natural history of penile cancer. Urology. 2010 Aug;76(2 Suppl 1):S2-6. doi: https://doi.org/10.1016/j.urology.2010.03.003
Castellsagué X, Bosch FX, Muñoz N, Meijer CJLM, Shah KV, de Sanjose S, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. The New England Journal of Medicine. 2002 Apr 11;346(15):1105–12. doi: https://doi.org/10.1056/nejmoa011688
Hellberg D, Valentin J, Eklund T, Nilsson S. Penile cancer: is there an epidemiological role for smoking and sexual behaviour? Br Med J (Clin Res Ed). 1987;295(6609):1306–8. doi: https://dx.doi.org/10.1136%2Fbmj.295.6609.1306
Kamel MH, Tao J, Su J, Khalil MI, Bissada NK, Schurhamer B, et al. Survival outcomes of organ sparing surgery, partial penectomy, and total penectomy in pathological T1/T2 penile cancer: Report from the National Cancer Data Base. Urologic Oncology. 2018;36(2):82.e7-82.e15. doi: https://doi.org/10.1016/j.urolonc.2017.10.017
Agrawal A, Pai D, Ananthakrishnan N, Smile SR, Ratnakar C. The histological extent of the local spread of carcinoma of the penis and its therapeutic implications. BJU international. 2000 Feb;85(3):299–301. doi: https://doi.org/10.1046/j.1464-410x.2000.00413.x
Hakenberg OW, Compérat E, Minhas S, Necchi A, Protzel C, Watkin. EAU Guidelines: Penile Cancer. Uroweb. [accessed 7 Oct 2020] Available from: https://uroweb.org/guideline/penile-cancer/
Niyogi D, Noronha J, Pal M, Bakshi G, Prakash G. Management of clinically node-negative groin in patients with penile cancer. Indian journal of urology: IJU: journal of the Urological Society of India. 2020 Mar;36(1):8–15. doi: https://doi.org/10.4103/iju.iju_221_19
Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU international. 2001 Sep;88(5):473–83. doi: https://doi.org/10.1046/j.1464-410x.2001.00379.x
Solsona E., Iborra I., Rubio J., Casanova J.l., Ricós J.v., Calabuig C. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. Journal of Urology. 2001 May 1;165(5):1506–9. doi: https://doi.org/10.1016/S0022-5347(05)66337-9
Chaux A, Caballero C, Soares F, Guimarães GC, Cunha IW, Reuter V, et al. The Prognostic Index: A Useful Pathologic Guide for Prediction of Nodal Metastases and Survival in Penile Squamous Cell Carcinoma. The American Journal of Surgical Pathology. 2009 Jul;33(7):1049–1057. doi: https://doi.org/10.1097/pas.0b013e31819d17eb
Ornellas AA. Management of penile cancer. Journal of surgical oncology. 2008;97(3):199. doi: https://doi.org/10.1002/jso.20893
Zhou X, Qi F, Zhou R, Wang S, Wang Y, Wang Y, et al. The role of perineural invasion in penile cancer: a meta-analysis and systematic review. Bioscience Reports. 2018 31;38(5). doi: https://doi.org/10.1042/bsr20180333
Cindolo L, Spiess PE, Bada M, Chipollini JJ, Nyirády P, Chiodini P, et al. Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study. World Journal of Urology. 2019 Aug;37(8):1649–57. doi: https://doi.org/10.1007/s00345-018-2549-3
